These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 21918813)

  • 21. HIV Vpr protein upregulates microRNA-122 expression and stimulates hepatitis C virus replication.
    Peng M; Xiao X; He Y; Jiang Y; Zhang M; Peng F; Tian Y; Xu Y; Gong G
    J Gen Virol; 2015 Aug; 96(8):2453-2463. PubMed ID: 25920531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Viral protein R (Vpr)-induced neuroinflammation and its potential contribution to neuronal dysfunction: a scoping review.
    Williams ME; Williams AA; Naudé PJW
    BMC Infect Dis; 2023 Aug; 23(1):512. PubMed ID: 37545000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Focal glomerulosclerosis in proviral and c-fms transgenic mice links Vpr expression to HIV-associated nephropathy.
    Dickie P; Roberts A; Uwiera R; Witmer J; Sharma K; Kopp JB
    Virology; 2004 Apr; 322(1):69-81. PubMed ID: 15063118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human immunodeficiency virus type 1 Vpr-dependent cell cycle arrest through a mitogen-activated protein kinase signal transduction pathway.
    Yoshizuka N; Yoshizuka-Chadani Y; Krishnan V; Zeichner SL
    J Virol; 2005 Sep; 79(17):11366-81. PubMed ID: 16103188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic variation and HIV-associated neurologic disease.
    Dahiya S; Irish BP; Nonnemacher MR; Wigdahl B
    Adv Virus Res; 2013; 87():183-240. PubMed ID: 23809924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuropathologies in transgenic mice expressing human immunodeficiency virus type 1 Tat protein under the regulation of the astrocyte-specific glial fibrillary acidic protein promoter and doxycycline.
    Kim BO; Liu Y; Ruan Y; Xu ZC; Schantz L; He JJ
    Am J Pathol; 2003 May; 162(5):1693-707. PubMed ID: 12707054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV-1 Vpr disrupts mitochondria axonal transport and accelerates neuronal aging.
    Wang Y; Santerre M; Tempera I; Martin K; Mukerjee R; Sawaya BE
    Neuropharmacology; 2017 May; 117():364-375. PubMed ID: 28212984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Defining the roles for Vpr in HIV-1-associated neuropathogenesis.
    James T; Nonnemacher MR; Wigdahl B; Krebs FC
    J Neurovirol; 2016 Aug; 22(4):403-15. PubMed ID: 27056720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV-1 Vpr suppresses the cytomegalovirus promoter in a CRL4(DCAF1) E3 ligase independent manner.
    Liu X; Guo H; Wang H; Markham R; Wei W; Yu XF
    Biochem Biophys Res Commun; 2015 Apr; 459(2):214-219. PubMed ID: 25704090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Virion-associated Vpr of human immunodeficiency virus type 1 triggers activation of apoptotic events and enhances fas-induced apoptosis in human T cells.
    Arokium H; Kamata M; Chen I
    J Virol; 2009 Nov; 83(21):11283-97. PubMed ID: 19692467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of Heme Oxygenase-1 Deficiency and Associated Glutamate-Mediated Neurotoxicity Is a Highly Conserved HIV Phenotype of Chronic Macrophage Infection That Is Resistant to Antiretroviral Therapy.
    Gill AJ; Kovacsics CE; Vance PJ; Collman RG; Kolson DL
    J Virol; 2015 Oct; 89(20):10656-67. PubMed ID: 26269184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV-1 Vpr potently induces programmed cell death in the CNS in vivo.
    Cheng X; Mukhtar M; Acheampong EA; Srinivasan A; Rafi M; Pomerantz RJ; Parveen Z
    DNA Cell Biol; 2007 Feb; 26(2):116-31. PubMed ID: 17328670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV1-viral protein R (Vpr) mutations: associated phenotypes and relevance for clinical pathologies.
    Soares R; Rocha G; Meliço-Silvestre A; Gonçalves T
    Rev Med Virol; 2016 Sep; 26(5):314-29. PubMed ID: 27264019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV-1 accessory protein Vpr: relevance in the pathogenesis of HIV and potential for therapeutic intervention.
    Kogan M; Rappaport J
    Retrovirology; 2011 Apr; 8():25. PubMed ID: 21489275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human immunodeficiency virus type 1 Nef protein mediates neural cell death: a neurotoxic role for IP-10.
    van Marle G; Henry S; Todoruk T; Sullivan A; Silva C; Rourke SB; Holden J; McArthur JC; Gill MJ; Power C
    Virology; 2004 Nov; 329(2):302-18. PubMed ID: 15518810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular insight into how HIV-1 Vpr protein impairs cell growth through two genetically distinct pathways.
    Maudet C; Bertrand M; Le Rouzic E; Lahouassa H; Ayinde D; Nisole S; Goujon C; Cimarelli A; Margottin-Goguet F; Transy C
    J Biol Chem; 2011 Jul; 286(27):23742-52. PubMed ID: 21566118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of NKG2D-mediated cytotoxic functions of natural killer cells by viral protein R from HIV-1 primary isolates.
    Pham TN; Richard J; Gerard FC; Power C; Cohen ÉA
    J Virol; 2011 Dec; 85(23):12254-61. PubMed ID: 21957298
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human immunodeficiency virus type 1 Vpr: functions and molecular interactions.
    Romani B; Engelbrecht S
    J Gen Virol; 2009 Aug; 90(Pt 8):1795-1805. PubMed ID: 19458171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Murine models of Vpr-mediated pathogenesis.
    Snyder A; Ross MJ
    Curr HIV Res; 2009 Mar; 7(2):129-35. PubMed ID: 19275581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The apoptosis-inducing effects of HIV Vpr recombinant eukaryotic expression vectors with different mutation sites on transfected Hela cells.
    Zheng Y; Zhou H; Zhang C; He Y; Li H; Chen Z; Liu M
    Curr HIV Res; 2009 Sep; 7(5):519-25. PubMed ID: 19925402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.